---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-023794"
form_type: "8-K"
ticker: "BKYI"
cik: "0001019034"
company_name: "BIO KEY INTERNATIONAL INC"
filed_at: "2023-08-15T23:59:59+00:00"
generated_at: "2026-06-11T09:07:17.856812+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# BIO-key Q2 revenue flat at $1.9M; net loss narrows to $1.4M

## Summary
- Q2 revenue $1.9M flat YoY; first-half revenue up 29% to $5.9M.
- Q2 gross margin improved to 69% from 63%; gross profit $1.3M up 8%.
- Q2 net loss narrowed to $1.4M from $1.7M; operating expenses down 10%.
- Signed $0.3M defense ministry order in early Q3; expanding EMEA partnerships.
- Management confident in FY2023 top-line growth and bottom-line improvements.

## SEC filing metadata
- accession: 0001437749-23-023794
- form_type: 8-K
- ticker: BKYI
- cik: 0001019034
- company_name: BIO KEY INTERNATIONAL INC
- filed_at: 2023-08-15T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1019034/000143774923023794/0001437749-23-023794-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1019034/000143774923023794/bkyi20230814_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-023794
- JSON: https://secwatch.observer/filing/0001437749-23-023794.json
- Plain text: https://secwatch.observer/filing/0001437749-23-023794.txt

## Key facts
- Earnings Releases
  BIO KEY INTERNATIONAL INC reported second quarter ended June 30, 2023 results: revenue $1.9M, net income $1.4M.
  - Period: second quarter ended June 30, 2023
  - Revenue: $1.9M
  - Net income: $1.4M
  - Result: reported results
  source text: filing. --- EX-99.1 (EXHIBIT 99.1) --- EX-99.1 2 ex_560801.htm EXHIBIT 99.1 ex_560801.htm Exhibit 99.1 Identity and Access Management Provider BIO-key Reports Q2 Revenue of $1.9M; Hosts Investor Call Tomorrow, August 15 th at 10am ET WALL, NJ – August 14, 2023 - BIO-key ® International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and
  evidence_url: https://www.sec.gov/Archives/edgar/data/1019034/000143774923023794/0001437749-23-023794-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.